autologous tolerogenic dendritic cell therapy (Russian Academy of Medical Sciences)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameautologous tolerogenic dendritic cell therapy (Russian Academy of Medical Sciences)

Drug Alias Nameautologous tolerogenic dendritic cell therapy (Russian Academy of Medical Sciences)dendritic cell therapy (Russian Academy of Medical Sciences)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRussian Academy Of Sciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRussian Academy Of Sciences

Active IndicationsN/A

Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A